Vortioxetine mitigates neuronal damage by restricting PERK/eIF2α/ATF4/CHOP signaling pathway in rats subjected to focal cerebral ischemia-reperfusion
Amr M. Emam, Muhammed A. Saad, Naglaa A. Ahmed, Hala F. Zaki
Topics & Concepts
NeuroprotectionCHOPMedicinePharmacologyIschemiaHippocampal formationStroke (engine)ATF4AnesthesiaVortioxetineMiddle cerebral arteryOxidative stressAntidepressantHippocampusInternal medicineChemotherapyEngineeringMechanical engineeringEndoplasmic Reticulum Stress and DiseaseNerve injury and regenerationTryptophan and brain disorders